Volume 11, Number 6—June 2005
Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States
|No. (N = 32)||%||No. (N = 724)||%|
|without coexisting factors||6||19||240||33|
|with coexisting factors||1||3||79||11|
|Location of time of culture|
|Intensive care unit||0||0||24||3|
|Long-term care facility||6||19||147||20|
|Transitional care unit||12||38||19||3|
|Skin and soft tissue||4||13||400||55|
|>65 years of age||19||59||353||49|
|Prior antimicrobial therapy||5||16||210||29|
*VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant Staphylococcus aureus.
†There were 2 VRE cases in which cultures were obtained in the community setting in patients with previous history of healthcare exposure (recent hospitalization, residence in long-term care facility).
‡There were 72 MRSA cases in which cultures were obtained in the community setting in patients with previous history of healthcare exposure. The location at the time of culture was unknown in one MRSA case.
- Page created: April 24, 2012
- Page last updated: April 24, 2012
- Page last reviewed: April 24, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)